Gene expression of fatty acid transport and binding proteins in the blood-brain barrier and the cerebral cortex of the rat: Differences across development and with different DHA brain status

Prostaglandins Leukotrienes and Essential Fatty Acids

Volumn 91, Issue 5, 2014, Pages 213-220

  Pélerin, Hélène ^a   Jouin, Mélanie ^a   Lallemand, Marie Sylvie ^a   Alessandri, Jean Marc ^a   Cunnane, Stephen C ^b   Langelier, Bénédicte ^a   Guesnet, Philippe ^c  

^a INRA   (France)

^b UNIVERSITÉ DE SHERBROOKE   (Canada)

^c PG Consulting   (France)

Author keywords

Blood brain barrier; Brain; Development; DHA status; Fatty acid transport proteins; Long chain polyunsaturated fatty acids

Indexed keywords

CD36 ANTIGEN; DOCOSAHEXAENOIC ACID; FATTY ACID BINDING PROTEIN; FATTY ACID BINDING PROTEIN 3; FATTY ACID BINDING PROTEIN 5; FATTY ACID BINDING PROTEIN 7; FATTY ACID TRANSPORTER; FATTY ACID TRANSPORTER 1; FATTY ACID TRANSPORTER 4; LONG CHAIN FATTY ACID COENZYME A LIGASE; LONG CHAIN FATTY ACID COENZYME A LIGASE 1; LONG CHAIN FATTY ACID COENZYME A LIGASE 3; LONG CHAIN FATTY ACID COENZYME A LIGASE 4; LONG CHAIN FATTY ACID COENZYME A LIGASE 6; MESSENGER RNA; PHOSPHATIDYLCHOLINE; PHOSPHATIDYLETHANOLAMINE; UNCLASSIFIED DRUG; OMEGA 3 FATTY ACID;

AGE; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BLOOD BRAIN BARRIER; BRAIN BLOOD VESSEL; BRAIN CORTEX; BRAIN DEVELOPMENT; CONTROLLED STUDY; DIET SUPPLEMENTATION; DIFFUSION; EMBRYO DEVELOPMENT; ENDOTHELIUM CELL; FATTY ACID ANALYSIS; FEMALE; GENE EXPRESSION; LIPID COMPOSITION; MALE; NONHUMAN; NUCLEOTIDE SEQUENCE; PERINATAL PERIOD; PROTEIN TRANSPORT; RAT; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WEANING; ANIMAL; BIOSYNTHESIS; DRUG EFFECTS; GENE EXPRESSION REGULATION; GENETICS; GROWTH, DEVELOPMENT AND AGING; METABOLISM;

ANIMALS; BLOOD-BRAIN BARRIER; CEREBRAL CORTEX; DOCOSAHEXAENOIC ACIDS; EMBRYONIC DEVELOPMENT; FATTY ACID TRANSPORT PROTEINS; FATTY ACID-BINDING PROTEINS; FATTY ACIDS, OMEGA-3; GENE EXPRESSION REGULATION; RATS; RNA, MESSENGER;

EID: 84908155710     PISSN: 09523278     EISSN: 15322823     Source Type: Journal    
DOI: 10.1016/j.plefa.2014.07.004     Document Type: Article

References (50)

1. Innis S.M. Essential fatty acids in growth and development. Prog. Lipid Res. 1991, 30:39-103.
2. Lauritzen L., Hansen H.S., Jørgensen M.H., Michaelsen K.F. The essentiality of long chain n-3 fatty acids in relation to development and function of the brain and retina. Prog. Lipid Res. 2001, 40:1-94.
3. Alessandri J.-M., Guesnet P., Vancassel S., et al. Polyunsaturated fatty acids in the central nervous system: evolution of concepts and nutritional implications throughout life. Reprod. Nutr. Dev. 2004, 44:509-538.
4. Innis S.M. Dietary omega 3 fatty acids and the developing brain. Brain Res. 2008, 1237:35-43.
5. Guesnet P., Alessandri J.-M. Docosahexaenoic acid (DHA) and the developing central nervous system (CNS) - Implications for dietary recommendations. Biochimie 2011, 93:7-12.
6. Kishimoto Y., Davies W.E., Radin N.S. Developing rat brain: changes in cholesterol, galactolipids, and the individual fatty acids of gangliosides and glycerophosphatides. J. Lipid Res. 1965, 6:532-536.
7. Poumès-Ballihaut C., Langelier B., Houlier F., et al. Comparative bioavailability of dietary alpha-linolenic and docosahexaenoic acids in the growing rat. Lipids 2001, 36:793-800.
8. Cunnane S.C., Francescutti V., Brenna J.T., Crawford M.A. Breast-fed infants achieve a higher rate of brain and whole body docosahexaenoate accumulation than formula-fed infants not consuming dietary docosahexaenoate. Lipids 2000, 35:105-111.
9. Umhau J.C., Zhou W., Carson R.E., et al. Imaging incorporation of circulating docosahexaenoic acid into the human brain using positron emission tomography. J. Lipid Res. 2009, 50:1259-1268.
10. Chalon S. Omega-3 fatty acids and monoamine neurotransmission. Prostaglandins Leukot. Essent. Fat. Acids 2006, 75:259-269.
11. Harbeby E., Jouin M., Alessandri J.-M., et al. n-3 PUFA status affects expression of genes involved in neuroenergetics differently in the fronto-parietal cortex compared to the CA1 area of the hippocampus: effect of rest and neuronal activation in the rat. Prostaglandins Leukot. Essent. Fat. Acids 2012, 86:211-220.
12. Jr Demar J.C., Ma K., Chang L., Bell J.M., Rapoport S.I. alpha-Linolenic acid does not contribute appreciably to docosahexaenoic acid within brain phospholipids of adult rats fed a diet enriched in docosahexaenoic acid. J. Neurochem. 2005, 94:1063-1076.
13. DeMar J.C., Lee H.J., Ma K., et al. Brain elongation of linoleic acid is a negligible source of the arachidonate in brain phospholipids of adult rats. Biochim. Biophys. Acta 2006, 1761:1050-1059.
14. Hamilton J.A., Brunaldi K. A model for fatty acid transport into the brain. J. Mol. Neurosci. 2007, 33:12-17.
15. Chen C.T., Green J.T., Orr S.K., Bazinet R.P. Regulation of brain polyunsaturated fatty acid uptake and turnover. Prostaglandins Leukot. Essent. Fat. Acids 2008, 79:85-91.
16. Chen C.T., Ma D.W., Kim J.H., Mount H.T., Bazinet R.P. The low density lipoprotein receptor is not necessary for maintaining mouse brain polyunsaturated fatty acid concentrations. J. Lipid Res. 2008, 49:147-152.
17. Rahman T., Taha A.Y., Song B.J., Orr S.K., Liu Z., Chen C.T., Bazinet R.P. The very low density lipoprotein receptor is not necessary for maintaining brain polyunsaturated fatty acid concentrations. Prostaglandins Leukot. Essent. Fat. Acids 2010, 82:141-145.
18. Ouellet M., Emond V., Chen C.T., et al. Diffusion of docosahexaenoic and eicosapentaenoic acids through the blood-brain barrier: an in situ cerebral perfusion study. Neurochem. Int. 2009, 55:476-482.
19. Mitchell R.W., On N.H., Del Bigio M.R., Miller D.W., Hatch G.M. Fatty acid transport protein expression in human brain and potential role in fatty acid transport across human brain microvessel endothelial cells. J. Neurochem. 2011, 117:735-746.
20. Mitchell R.W., Edmundson C.L., Miller D.W., Hatch G.M. On the mechanism of oleate transport across human brain microvessel endothelial cells. J. Neurochem. 2009, 110:1049-1057.
21. Liu R.Z., Mita R., Beaulieu M., Gao Z., Godbout R. Fatty acid binding proteins in brain development and disease. Int. J. Dev. Biol. 2010, 54:1229-1239.
22. Doege H., Stahl A. Protein-mediated fatty acid uptake: novel insights from in vivo models. Physiology 2006, 21:259-268.
23. Owada Y. Fatty acid binding protein: localization and functional significance in the brain. Tohoku J. Exp. Sci. 2008, 214:213-220.
24. Guesnet P., Alasnier C., Alessandri J.-M., Durand G. Modifying the n-3 fatty acid content of the maternal diet to determine the requirements of the fetal and suckling rat. Lipids 1997, 32:527-534.
25. Larqué E., Krauss-Etschmann S., Campoy C., Hartl D., Linde J., Klingler M., Demmelmair H., Caño A., Gil A., Bondy B., Koletzko B. Docosahexaenoic acid supply in pregnancy affects placental expression of fatty acid transport proteins. Am. J. Clin. Nutr. 2006, 84:853-861.
26. Abbott N.J., Patabendige A.A., Dolman D.E., Yusof S.R., Begley D.J. Structure and function of the blood-brain barrier. Neurobiol. Dis. 2010, 37:13-25.
27. Perrière N., Demeuse P., Garcia E., et al. Puromycin-based purification of rat brain capillary endothelial cell cultures. Effect on the expression of blood-brain barrier-specific properties. J. Neurochem. 2005, 93:279-289.
28. Pifferi F., Jouin M., Alessandri J.-M., et al. n-3 long-chain fatty acids and regulation of glucose transport in two models of rat brain endothelial cells. Neurochem. Int. 2010, 56:703-710.
29. Langelier B., Alessandri J.-M., Perruchot M.-H., Guesnet P., Lavialle M. Changes of the transcriptional and fatty acid profiles in response to n-3 fatty acids in SH-SY5Y neuroblastoma cells. Lipids 2005, 40:719-728.
30. Alessandri J.-M., Extier A., Al-Gubory K.H., et al. Ovariectomy and 17β-estradiol alter transcription of lipid metabolism genes and proportions of neo-formed n-3 and n-6 long-chain polyunsaturated fatty acids differently in brain and liver. J. Nutr. Biochem. 2011, 22:820-827.
31. Alessandri J.-M., Poumès-Ballihaut C., Langelier B., et al. Incorporation of docosahexaenoic acid into nerve membrane phospholipids: bridging the gap between animals and cultured cells. Am. J. Clin. Nutr. 2003, 78:702-710.
32. Massiera F., Barbry P., Guesnet P., et al. A western-like fat diet is sufficient to induce a gradual enhancement in fat mass over generations. J. Lipid Res. 2010, 51:2352-2361.
33. Mitchell R.W., Hatch G.M. Fatty acid transport into the brain: of fatty acid fables and lipid tails. Prostaglandins Leukot. Essent. Fat. Acids 2011, 85:293-302.
34. Eyre N.S., Cleland L.G., Mayrhofer G. FAT/CD36 expression alone is insufficient to enhance cellular uptake of oleate. Biochem. Biophys. Res. Commun. 2008, 370:404-409.
35. Chabowski A., Górski J., Luiken J.J., Glatz J.F., Bonen A. Evidence for concerted action of FAT/CD36 and FABPpm to increase fatty acid transport across the plasma membrane. Prostaglandins Leukot. Essent. Fat. Acids 2007, 77:345-353.
36. Husemann J., Loike J.D., Anankov R., Febbraio M., Silverstein S.C. Scavenger receptors in neurobiology and neuropathology: their role on microglia and other cells of the nervous system. Glia 2002, 40:195-205.
37. Glezer I., Bittencourt J.C., Rivest S. Neuronal expression of Cd36, Cd44, and Cd83 antigen transcripts maps to distinct and specific murine brain circuits. J. Comp. Neurol. 2009, 517:906-924.
38. Song B.J., Elbert A., Rahman T., Orr S.K., Chen C.T., Febbraio M., Bazinet R.P. Genetic ablation of CD36 does not alter mouse brain polyunsaturated fatty acid concentrations. Lipids 2010, 45:291-299.
39. Xu S., Jay A., Brunaldi K., Huang N., Hamilton J.A. CD36 enhances fatty acid uptake by increasing the rate of intracellular esterification but not transport across the plasma membrane. Biochemistry 2013, 52:7254-7261.
40. Digel M., Ehehalt R., Stremmel W., Füllekrug J. Acyl-CoA synthetases: fatty acid uptake and metabolic channelling. Mol. Cell. Biochem. 2009, 326:23-28.
41. Frohnert B.I., Bernlohr D.A. Regulation of fatty acid transporters in mammalian cells. Prog. Lipid Res. 2000, 39:83-107.
42. Hall A.M., Wiczer B.M., Herrmann T., Stremmel W., Bernlohr D.A. Enzymatic properties of purified murine fatty acid transport protein 4 and analysis of acyl-CoA synthetase activities in tissues from FATP4 null mice. J. Biol. Chem. 2005, 280:11948-11954.
43. Gargiulo C.E., Stuhlsatz-Krouper S.M., Schaffer J.E. Localization of adipocyte long-chain fatty acyl-CoA synthetase at the plasma membrane. J. Lipid Res. 1999, 40:881-892.
44. Richards M.R., Harp J.D., Ory D.S., Schaffer J.E. Fatty acid transport protein 1 and long-chain acyl coenzyme A synthetase 1 interact in adipocytes. J. Lipid Res. 2006, 47:665-672.
45. Mashek D.G., Li L.O., Coleman R.A. Rat long-chain acyl-CoA synthetase mRNA, protein, and activity vary in tissue distribution and in response to diet. J. Lipid Res. 2006, 47:2004-2010.
46. Marszalek J.R., Kitidis C., Dararutana A., Lodish H.F. Acyl-CoA synthetase 2 overexpression enhances fatty acid internalization and neurite outgrowth. J. Biol. Chem. 2004, 279:23882-23891.
47. Marszalek J.R., Kitidis C., Dirusso C.C., Lodish H.F. Long-chain acyl-CoA synthetase 6 preferentially promotes DHA metabolism. J. Biol. Chem. 2005, 280:10817-10826.
48. Shimshoni J.A., Basselin M., Li L.O., Coleman R.A., Rapoport S.I., Modi H.R. Valproate uncompetitively inhibits arachidonic acid acylation by rat acyl-CoA synthetase 4: relevance to valproate[U+05F3]s efficacy against bipolar disorder. Biochim. Biophys. Acta 2011, 1811:163-169.
49. Storch J., Thumser A.E. Tissue-specific functions in the fatty acid-binding protein family. J. Biol. Chem. 2010, 285:32679-32683.
50. Edmond J. Essential polyunsaturated fatty acids and the barrier to the brain: the components of a model for transport. J. Mol. Neurosci. 2001, 16:181-193.